OMDA as reported
Omada Health, Inc. reported $283M of revenue over the trailing twelve months, +49% on the year before. 9 reported series are charted on this page, each one as filed.
$283M
Revenue, trailing twelve months · to Q1 2026 · +49% against the twelve months before
- Net Income
- −$6.3M
Net Income · −83% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- $21M
Free Cash Flow · trailing twelve months to Q1 2026
- Op Margin
- −3.1%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $283M | +49% | Q1 2026 |
| Net Income | −$6.3M | −83% | Q1 2026 |
| EPS | −$0.09 | −98% | Q1 2026 |
| Gross Margin | 66% | n/a | Q1 2026 |
| Op Margin | −3.1% | n/a | Q1 2026 |
| Net Margin | −2.6% | n/a | Q1 2026 |
| ROE | −8.8% | n/a | Q1 2026 |
| ROA | −6.5% | n/a | Q1 2026 |
| Free Cash Flow | $21M | n/a | Q1 2026 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Omada Health, Inc. (OMDA) - Revenue & ProfitRevenue & ProfitOmada Health, Inc. (OMDA)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Health Information Services
Ranks #4 of 14 by Smart Score